Schedule 13G ownership disclosure

Cytokinetics Inc

COMMON STOCK · CUSIP: 23282W605

Event date: 2025-06-30

Filing-level shares
17,602,440
Percent of class
14.7%
  • T. Rowe Price Investment Management, Inc.

    Shares: 17,602,440 · Class: 14.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-25-000356
Form type
SCHEDULE 13G/A
Filer
CYTOKINETICS INC
CIK
CIK 1061983
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub